The first DePuy ASR defective hip implant trial to hit a courtroom in the United States has been settled. The trial was scheduled to be heard in December in a Las Vegas, Nevada courtroom. The case involved three plaintiffs who were implanted with DePuy Orthopaedics ASR hip replacement devices, and were forced to undergo risky revision surgery.
The next DePuy ASR jury trial is scheduled for January 2013 in a Maryland state court. The Maryland trial also involves three plaintiffs who received the DePuy ASR and had to under revision surgery. If this case is not resolved prior to going to trial, then DePuy Orthopaedics, a subsidiary of Johnson & Johnson will have to explain the defects in the ASR device, the Atlanta Legal Examiner reports.
Thousands of DePuy ASR hip recipients have filed lawsuits against the company in state and federal courts across the country alleging the device is defective and seeking damages for pain and suffering and limited mobility, among other things. The ASR device is a metal-on-metal replacement system, which has been found to release chromium and cobalt into the blood and causing an inflammatory response at the site, while the metal debris is believed to cause damage to nearby tissue.